• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Neurokine Pharmaceuticals Inc

+ Add to Watchlist


0.003 EUR 0.0000.00%

As of 02:00:28 ET on 08/20/2014.

Snapshot for Neurokine Pharmaceuticals Inc (NPAS)

Open: 0.003 Day's Range: 0.003 - 0.003 Volume: 0
Previous Close: 0.003 52wk Range: 0.001 - 0.029 1-Yr Rtn: +200.00%

Stock Chart for NPAS

No chart data available.
  • NPAS:GR 0.003
  • 1M
  • 1Y
Interactive NPAS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NPAS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.35
Shares Outstanding (M) 115.77
30 Day Average Volume 667
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/16/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NPAS

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for NPAS

Neurokine Pharmaceuticals, Inc. is a biopharmaceutical research company. The Company primarily researches new therapeutic uses for existing drugs. Neurokine researches neurocognitive impairment in post coronary artery bypass graft patients, degenerative central nervous system diseases, and degenerative disk disease.

Ahmad DoroudianPresident/CEO/SecretaryMoira OngCFO/Principal Acctg Officer
More Company Profile & Key Executives for NPAS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil